Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SAFESKIN -- Ignore unavailable to you. Want to Upgrade?

To: TheDad who wrote (593)	3/1/1999 1:18:00 PM
From: Beltropolis Boy	Respond to of 828

>The recent movement (or lack thereof) has been disappointing at best. Does anyone have any information they can share? daddy-o. i'll admit, my enthusiasm has been deflated a bit too. then again, SFSK may be a decent defensive posture in this market. i'm taking a whacking on the shins with intel. on paper, anyway. sorry i can't be of more help, -chris. via today's san diego union-trib. ----- Safeskin gets a hand By Don Bauder February 28, 1999 Safeskin, the maker of medical rubber and latex gloves, has been "skinned by Wall Street but still is safe," says Richard J. Moroney of Dow Theory Forecasts in Hammond, Ind., and he's issued a buy recommendation. The shares were sliced 60 percent between July and December and now trade at one of the lowest multiples to earnings and cash flow since the stock went public in late 1993, Moroney says. He says Safeskin has 60 percent of the powder-free glove market in the United States. Safeskin took a fourth-quarter charge of $15 million to cover the costs of moving equipment from California and Malaysia to facilities in Thailand. Without that charge, operating earnings rose 30 percent in the quarter, and per-share earnings before charges were up 41 percent for the full year, as sales rose 30 percent. However, the company has added more than $122 million in debt, $70 million of which went to buy back shares. "Safeskin represents a defensive stock trading at a good value," Moroney says. uniontrib.com